02/03/2026
After decades of research, one of the most anticipated tinnitus treatments is on its way to becoming a reality. Today, we're talking with the people making it happen.
Dr. Susan Shore (ATA-funded researcher & Co-Founder and CSO of Auricle Inc.) and CEO Jon Pearson join us to discuss the journey from university lab to clinical device and why getting there took longer than anyone expected, but for all the right reasons.
They're diving into the research that led to Auricle's bimodal neuromodulation device, why clinical trials and FDA approval can't be rushed, and what it takes to turn rigorous science into accessible treatment.
No hype, no shortcuts, just an honest look at what evidence-based medicine requires, even when the need for relief is urgent.
Watch now: https://www.ata.org/taw2026/ -demand
𝘕𝘰𝘵𝘦: 𝘛𝘩𝘦 𝘈𝘮𝘦𝘳𝘪𝘤𝘢𝘯 𝘛𝘪𝘯𝘯𝘪𝘵𝘶𝘴 𝘈𝘴𝘴𝘰𝘤𝘪𝘢𝘵𝘪𝘰𝘯 𝘱𝘢𝘳𝘵𝘪𝘤𝘪𝘱𝘢𝘵𝘦𝘴 𝘪𝘯 𝘦𝘷𝘦𝘯𝘵𝘴 𝘢𝘯𝘥 𝘸𝘦𝘭𝘤𝘰𝘮𝘦𝘴 𝘴𝘶𝘱𝘱𝘰𝘳𝘵 𝘵𝘩𝘢𝘵 𝘢𝘭𝘪𝘨𝘯𝘴 𝘸𝘪𝘵𝘩 𝘰𝘶𝘳 𝘮𝘪𝘴𝘴𝘪𝘰𝘯 𝘵𝘰 𝘱𝘳𝘰𝘷𝘪𝘥𝘦 𝘤𝘳𝘦𝘥𝘪𝘣𝘭𝘦, 𝘦𝘷𝘪𝘥𝘦𝘯𝘤𝘦-𝘣𝘢𝘴𝘦𝘥 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯 𝘢𝘯𝘥 𝘩𝘦𝘭𝘱 𝘧𝘰𝘳 𝘱𝘦𝘰𝘱𝘭𝘦 𝘭𝘪𝘷𝘪𝘯𝘨 𝘸𝘪𝘵𝘩 𝘵𝘪𝘯𝘯𝘪𝘵𝘶𝘴. 𝘖𝘶𝘳 𝘪𝘯𝘷𝘰𝘭𝘷𝘦𝘮𝘦𝘯𝘵 𝘰𝘳 𝘥𝘰𝘯𝘰𝘳 𝘳𝘦𝘭𝘢𝘵𝘪𝘰𝘯𝘴𝘩𝘪𝘱𝘴 𝘥𝘰 𝘯𝘰𝘵 𝘪𝘮𝘱𝘭𝘺 𝘦𝘯𝘥𝘰𝘳𝘴𝘦𝘮𝘦𝘯𝘵 𝘰𝘧 𝘰𝘵𝘩𝘦𝘳 𝘴𝘱𝘦𝘢𝘬𝘦𝘳𝘴, 𝘴𝘱𝘰𝘯𝘴𝘰𝘳𝘴, 𝘰𝘳𝘨𝘢𝘯𝘪𝘻𝘢𝘵𝘪𝘰𝘯𝘴, 𝘴𝘱𝘦𝘤𝘪𝘧𝘪𝘤 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵𝘴, 𝘱𝘳𝘰𝘥𝘶𝘤𝘵𝘴, 𝘥𝘦𝘷𝘪𝘤𝘦𝘴, 𝘰𝘳 𝘷𝘪𝘦𝘸𝘱𝘰𝘪𝘯𝘵𝘴.